FOLH1 and prostate cancer: To our awareness, however, no previously published report has specifically focused on the utility of 68Ga-PSMA in identifying sites of relapsed prostate cancer within the pelvis, in the setting of localized or oligometastatic disease, and determining suitable candidates for salvage RT (SRT).